5-aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease?

被引：4
|
作者：
Desreumaux, P [1 ]
Romano, O [1 ]
机构：
[1] Univ Lille, Equipe INSERM, Serv Maladies Appareil Digestif, F-0114 Lille, France
来源：
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 2004年 / 28卷 / 05期
关键词：
D O I：
10.1016/S0399-8320(04)94978-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：509 / 509
页数：1
相关论文
共 50 条
  • [21] Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease
    Eaden, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 : 15 - 21
  • [22] The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease
    U. Klotz
    European Journal of Clinical Pharmacology, 2000, 56 : 353 - 362
  • [23] The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease
    Klotz, U
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (05) : 353 - 362
  • [24] AMINOSALICYLATES IN THE TREATMENT OF CHRONIC INFLAMMATORY BOWEL-DISEASE
    HARTMANN, F
    PLAUTH, M
    INTERNIST, 1990, 31 (11): : 702 - 706
  • [25] Differences in expression of PPARγ in small intestine vs. colon impact the effect of 5-aminosalicylates in inflammatory bowel disease
    Bakke, I.
    Bruland, T.
    Eriksen, K. S.
    Skovdahl, H. K.
    Gopalakrishnan, S.
    Thorsvik, S.
    Granlund, A. V. B.
    Sandvik, A. K.
    Ostvik, A. E.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S182 - S182
  • [26] Differential Risk of Colorectal Cancer in Inflammatory Bowel Disease Patients Treated With Advanced Therapies, Immunomodulators, and 5-Aminosalicylates: A Multi-Research Network Study Utilizing the TrinetX Database
    Mansoor, Emad
    Perez, Abe
    Schlick, Kayla
    Alkhayyat, Motasem
    Tanner, Samuel
    Kelly, Hannah
    Abou-Saleh, Mohannad
    Sinh, Preetika
    Cominelli, Fabio
    Katz, Jeffry
    Regueiro, Miguel
    Cooper, Gregory
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S457 - S457
  • [27] Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
    Park, Jihye
    Cheon, Jae Hee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2022, 37 (05): : 895 - 905
  • [28] Chronic inflammatory bowel disease in a pseudotumoral form improving on aminosalicylates
    Maamouri, N.
    Guellouz, S.
    Belkahla, N.
    Kchir, H.
    Mohsni, B.
    Haouet, S.
    Chouaib, S.
    Zitouna, M. M.
    Ben Mami, N.
    ACTA ENDOSCOPICA, 2011, 41 (05) : 301 - 302
  • [29] 5-aminosalicylates are not associated with adverse outcomes in Inflammatory Bowel Disease patients with COVID-19: Analysis from an international registry
    Ungaro, R.
    Brenner, E.
    Agrawal, M.
    Gearry, R. B.
    Kaplan, G. O.
    Kissous-Hunt, M.
    Ng, S. C.
    Rahier, J. F.
    Reinisch, W.
    Steinwurz, F.
    Zhang, X.
    Lewis, J. D.
    Kappelman, M. D.
    Colombel, J. F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S006 - S007
  • [30] Urinary glutathion-transferase dosage: A marker for identification of 5-aminosalicylates induced renal toxicity in patients with inflammatory bowel disease?
    Lefebvre, S
    Rousseau, A
    StLouis, G
    Godet, P
    Fugere, J
    Girardin, C
    GASTROENTEROLOGY, 1997, 112 (04) : A1025 - A1025
12345